Viewing Study NCT02027935


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2025-12-29 @ 2:35 PM
Study NCT ID: NCT02027935
Status: COMPLETED
Last Update Posted: 2024-10-08
First Post: 2014-01-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma
Sponsor: M.D. Anderson Cancer Center
Organization: